BRUCE L A CARTER
CIK 1225503 · CEO & Chairman of the Board · last filed 2026-03-13
BRUCE L A CARTER is a CEO & Chairman of the Board who has filed 66 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for ENTA, was dated Mar 13, 2026. Across all open-market trades the lifetime net is −$6.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.15M
7
66
-$6.23M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ENTA | Director | 807 | $11.90 | $9.6K | -$1.26M | 16 | 2026-03-13 |
| Mirati Therapeutics, Inc. (MRTX) Delisted | Director | 6,808 | $58.70 | $399.6K | -$3.95M | 20 | 2024-01-23 |
| XNCR | Director | 48,880 | $12.33 | $602.7K | -$1.01M | 7 | 2017-06-16 |
| Regulus Therapeutics Inc. (RGLS) Delisted | Director | 0 | $8.16 | $0 | -$353.2K | 5 | 2015-06-26 |
| QLTI | Director | 20,000 | $26.82 | $536.4K | $41.4K | 6 | 2011-05-27 |
| ZYMOGENETICS INC (ZGEN) Delisted | Director | 115,399 | $12.01 | $1.39M | $298.3K | 10 | 2010-10-12 |
| RENOVIS INC (RNVS) Delisted | Director | — | — | — | $0 | 1 | 2007-01-30 |
Recent Filings
66 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-13 | ENTA | Grant (A) | — | $0 | EDGAR |
| 2025-03-14 | ENTA | Grant (A) | — | $0 | EDGAR |
| 2024-03-08 | ENTA | Grant (A) | — | $0 | EDGAR |
| 2024-01-23 | Mirati Therapeutics, Inc. (MRTX) Delisted | Disp (D) | −17,273 | $0 | EDGAR |
| 2024-01-03 | Mirati Therapeutics, Inc. (MRTX) Delisted | Grant (A) | +6,808 | $400.0K | EDGAR |
| 2023-03-06 | ENTA | Grant (A) | — | $0 | EDGAR |
| 2023-01-24 | Mirati Therapeutics, Inc. (MRTX) Delisted | Grant (A) | +4,444 | $0 | EDGAR |
| 2022-08-16 | Mirati Therapeutics, Inc. (MRTX) Delisted | Mixed | — | -$584.9K | EDGAR |
| 2022-03-22 | ENTA | Mixed | — | -$253.5K | EDGAR |
| 2022-03-07 | ENTA | Grant (A) | — | $0 | EDGAR |